輸入代號或公司名稱後按 Enter
1784

訊聯

-0.20 (-0.34%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
58.3058成交張數54.17本益比2.38股價淨值比1.51%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入 · 未來期間為分析師共識預估(2026-09-09)

營業收入20251,237年增 +1.2%
毛利率202555.3%最新一期
營業利益率2025-1.2%最新一期
每股盈餘20251.02年增 -38.2%
會計項目走勢20162017201820192020202120222023202420252026 預估 1 家
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計50.5%47.5%42.5%45.6%48.9%45.4%44.7%43.4%43.9%44.7%
營業毛利(毛損)49.5%52.5%57.5%54.4%51.1%54.6%55.3%56.6%56.1%55.3%56.5%
營業毛利(毛損)淨額49.5%52.5%57.5%54.4%51.1%54.6%55.3%56.6%56.1%55.3%
營業費用合計53.0%52.9%53.0%53.3%51.5%51.2%49.5%49.1%51.0%56.5%
營業利益(損失)-3.6%-0.4%4.4%1.1%-0.5%3.4%5.8%7.5%5.1%-1.2%3.4%
稅前淨利(淨損)-2.3%0.2%5.9%3.3%0.8%4.5%7.2%9.5%8.4%1.6%
所得稅費用(利益)合計0.1%-0.1%1.1%0.6%0.6%0.9%1.7%2.3%2.6%1.5%
繼續營業單位本期淨利(淨損)-2.4%0.2%4.8%2.7%0.2%3.5%5.5%7.2%5.7%0.1%
本期淨利(淨損)-2.4%0.2%4.8%2.7%0.2%3.5%5.5%7.2%5.7%0.1%
本期綜合損益總額-2.5%0.2%5.0%2.6%0.1%3.5%5.4%7.1%5.4%-0.1%
母公司業主(淨利∕損)-1.4%-0.9%3.1%0.9%1.6%2.9%3.9%7.0%6.8%4.2%
基本每股盈餘-0.0%-0.0%0.1%0.0%0.0%0.1%0.1%0.1%0.1%0.1%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。最右邊的預估欄是分析師共識預估(2026-09-09),營收、營業利益、母公司淨利、每股盈餘直接取共識平均,毛利由共識營收乘上共識毛利率推算,不是公司財測。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。